BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7029503)

  • 1. Lupus nephritis and lupus band test.
    Adam BA; Wang F; Looi LM; Prathap K
    Postgrad Med J; 1981 Aug; 57(670):499-501. PubMed ID: 7029503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease.
    Gilliam JN; Cheatum DE; Hurd ER; Stastny P; Ziff M
    J Clin Invest; 1974 May; 53(5):1434-40. PubMed ID: 4596508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens.
    Jennette JC; Hipp CG
    Am J Clin Pathol; 1985 Apr; 83(4):415-20. PubMed ID: 3885712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of lupus nephritis by skin immunofluorescence, in the absence of extrarenal manifestations of systemic lupus erythematosus.
    Lief PD; Barland P; Bank N
    Am J Med; 1977 Sep; 63(3):441-8. PubMed ID: 331949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of a positive cutaneous immunofluorescence test in systemic lupus erythematosus.
    Dantzig PI; Mauro J; Rayhanzadeh S; Rudofsky UH
    Br J Dermatol; 1975 Nov; 93(5):531-7. PubMed ID: 1203177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of deposits of immunoglobulins G, A, M and C3 complement component in the basal membrane zone of clinically unchanged skin for the diagnosis and evaluation of systemic lupus erythematosus activity].
    Zecevic RD
    Vojnosanit Pregl; 2001; 58(4):369-74. PubMed ID: 11712217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of renal angiitis in systemic lupus erythematosus (SLE).
    Bhuyan UN; Malaviya AN; Dash SC; Malhotra KK
    Clin Nephrol; 1983 Sep; 20(3):109-13. PubMed ID: 6354537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of the lupus band test. Results in 18 patients with systemic lupus erythematosus.
    Jacobs MI; Schned ES; Bystryn JC
    Arch Dermatol; 1983 Nov; 119(11):883-9. PubMed ID: 6357104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathology of early and clinically silent lupus nephropathy.
    Cavallo T; Cameron WR; Lapenas D
    Am J Pathol; 1977 Apr; 87(1):1-18. PubMed ID: 322502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin immunopathology in system lupus erythematosus.
    Brown MM; Yount WJ
    JAMA; 1980 Jan; 243(1):38-42. PubMed ID: 6985675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
    Magil AB; Ballon HS; Chan V; Lirenman DS; Rae A; Sutton RA
    Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical usefulness of the lupus band test].
    Benoldi D; Manganelli P; Scioscioli S
    G Ital Dermatol Venereol; 1987 Oct; 122(10):495-7. PubMed ID: 3327807
    [No Abstract]   [Full Text] [Related]  

  • 13. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.
    Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA
    Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological parameters in lupus nephritis: their relevance for classification and relationship with clinical and histological findings and outcome.
    Banfi G; Mazzucco G; Barbiano di Belgiojoso G; Bestetti Bosisio M; Stratta P; Confalonieri R; Ferrario F; Imbasciati E; Monga G
    Q J Med; 1985 May; 55(217):153-68. PubMed ID: 3159033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma level of complement fractions C3 and C4 in children with glomerular nephropathies. Correlations with morphological and immunopathological studies of renal biopsies].
    Loirat C; Levy M
    Arch Fr Pediatr; 1976 Nov; 33(G):853-72. PubMed ID: 827270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary C2 deficiency and systemic lupus erythematosus associated with severe glomerulonephritis.
    Roberts JL; Schwartz MM; Lewis EJ
    Clin Exp Immunol; 1978 Feb; 31(2):328-38. PubMed ID: 348363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic tests and clinical subsets in systemic lupus erythematosus: update 1983.
    Weiss RA; Mogavero HS; Synkowski DR; Provost TT
    Ann Allergy; 1983 Aug; 51(2 Pt 1):135-46. PubMed ID: 6349429
    [No Abstract]   [Full Text] [Related]  

  • 18. Coexistence of bullous pemphigoid and systemic lupus erythematosus.
    Kumar V; Binder WL; Schotland E; Beutner EH; Chorzelski TP
    Arch Dermatol; 1978 Aug; 114(8):1187-90. PubMed ID: 354534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-lupus full house nephropathy in pediatrics: Case reports.
    Guerrero GA; Guerrero LF; González T
    Biomedica; 2020 Jun; 40(2):220-227. PubMed ID: 32673451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.